查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1391918

心臟自主神经控制市场：依产品类型、按应用、按最终用户、按地区

Cardiac Autonomic Control Market, By Product Type (Heart Rate Variability Monitors, Blood Pressure Monitors, ECG Monitors, and Others), By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球心臟自主控制市场预计将从2023年的168.4亿美元增加到2030年的277.6亿美元，复合年增长率为7.4%。

报告范围 报告详情
基准年 2022年 2023年市场规模 168.4亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 7.40% 2030年市场规模预测 277.6亿美元
图 1. 2023 年按地区分類的心臟自主控制全球市场占有率(%)
心臟自主控制市场-IMG1

全球心臟自主控制市场是更广泛的医疗保健产业中快速发展的部分。该市场包括各种旨在监测、诊断和治疗与心臟自主控制相关的疾病的产品和服务。心臟自主控制是一个复杂的过程，涉及中枢神经系统 (cANS) 对心率、血压和其他心血管系统功能的调节。该系统在维持心血管稳态和响应身体生理状态的变化方面发挥着重要作用。心臟自主控制市场包括各种诊断设备、治疗设备和相关服务。心率监测器、血压计和心电图 (ECG) 机等诊断设备用于评估 CANS 功能并检测异常情况。起搏器和植入式心臟整流去颤器(ICD) 等治疗设备用于治疗与心臟自主控制相关的疾病。该市场的推动因素包括心血管疾病盛行率的增加、医疗技术的进步以及人们对维持心血管健康重要性的认识不断提高。但市场也面临高成本、法规要求严格等挑战。总体而言，在医疗保健需求增加和技术进步的推动下，全球心臟自主控制市场预计将在未来几年显着成长。

市场动态：

心血管疾病盛行率的增加、医疗技术的进步以及人们对心臟健康意识的提高预计将在预测期内推动全球心臟自主控制市场的成长。此外，人工智慧和机器学习的整合预计也将在预测期内推动全球心臟自主控制市场的成长。技术进步、个人化医疗、远端患者监护和巨量资料分析预计将在预测期内为全球心臟自主控制市场提供成长机会。

然而，高成本、有限的意识和教育、复杂的监管环境以及资料隐私和安全问题预计将阻碍预测期内全球心臟自主控制市场的成长。

本研究的主要特点

  • 该研究报告对全球心臟自主神经系统控制市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030年）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球心臟自主控制市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 全球心臟自主控制市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球心臟自主控制市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 医疗科技的进步
  • 人们对心臟健康的认识不断增强
  • 整合人工智慧和机器学习
  • 个人化医疗
  • 远端患者监护
  • 巨量资料分析
  • 与远端医疗集成
  • 远端患者监护
  • 人工智慧和机器学习
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球心臟自主控制市场 -冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球心臟自主神经控制市场，依产品类型，2018-2030

  • 心率变异性 (HRV) 监测器
  • 血压计
  • 心电监视器
  • 其他的

第六章 全球心臟自主神经系统控制市场，依应用分类，2018-2030

  • 诊断
  • 治疗
  • 研究

第 7 章 全球心臟自主控制市场，依最终使用者划分，2018-2030 年

  • 医院和诊所
  • 家庭用户
  • 调查机构
  • 其他的

第八章2018-2030年全球心臟自主神经控制市场（按地区）

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik
  • MicroPort Scientific Corporation
  • LivaNova PLC
  • Nihon Kohden Corporation
  • Schiller AG
  • Johnson & Johnson
  • GE Healthcare
  • Fitbit
  • BIOTRONIK
  • Biobit
  • InBody

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6110

Global cardiac autonomic control market is estimated to reach US$ 27.76 bn by 2030, from US$ 16.84 bn in 2023, at a CAGR of 7.4%.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 16.84 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 7.40% 2030 Value Projection: US$ 27.76 Bn
Figure 1. Global Cardiac Autonomic Control Market Share (%), By Region, 2023
Cardiac Autonomic Control Market - IMG1

The global cardiac autonomic control market is a rapidly evolving sector within the broader healthcare industry. This market encompasses a range of products and services designed to monitor, diagnose, and treat conditions related to the autonomic control of the heart. The autonomic control of the heart is a complex process that involves the regulation of heart rate, blood pressure, and other cardiovascular functions by the central autonomic nervous system (cANS). This system plays a crucial role in maintaining cardiovascular homeostasis and responding to changes in the body's physiological state. The cardiac autonomic control market includes various diagnostic devices, therapeutic devices, and related services. Diagnostic devices such as heart rate monitors, blood pressure monitors, and electrocardiogram (ECG) machines are used to assess the functioning of the cANS and detect abnormalities. Therapeutic devices such as pacemakers and implantable cardioverter defibrillators (ICDs) are used to treat conditions related to autonomic control of the heart. The market is driven by factors such as the increasing prevalence of cardiovascular diseases, advancements in medical technology, and growing awareness about the importance of maintaining cardiovascular health. However, the market also faces challenges such as high costs of devices and stringent regulatory requirements. Overall, the global cardiac autonomic control market is expected to witness significant growth in the coming years, driven by increasing healthcare needs and technological advancements.

Market Dynamics:

Increasing prevalence of cardiovascular diseases, advancements in medical technology, and growing awareness about heart health are expected to drive growth of the global cardiac autonomic control market over the forecast period. Moreover, integration of artificial intelligence and machine learning is also expected to boost growth of the global cardiac autonomic control market over the forecast period. Technological advancements, personalized medicine, remote patient monitoring, and big data analytics are expected to create growth opportunities for the global cardiac autonomic control market during the forecast period.

However, high costs, limited awareness and education, complex regulatory landscape, and data privacy and security concerns are expected to hamper growth of the global cardiac autonomic control market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global cardiac autonomic control market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cardiac autonomic control market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik, MicroPort Scientific Corporation, LivaNova PLC, Nihon Kohden Corporation, Schiller AG, Johnson & Johnson, GE Healthcare, Fitbit, BIOTRONIK, Biobit, InBody
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cardiac autonomic control market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac autonomic control market

Detailed Segmentation:

  • Global Cardiac Autonomic Control Market, By Product Type:
    • Heart Rate Variability (HRV) Monitors
    • Blood Pressure Monitors
    • ECG Monitors
    • Others
  • Global Cardiac Autonomic Control Market, By Application:
    • Diagnostics
    • Therapeutics
    • Research
  • Global Cardiac Autonomic Control Market, By End User:
    • Hospitals and Clinics
    • Home Users
    • Research Institutes
    • Others
  • Global Cardiac Autonomic Control Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Biotronik
    • MicroPort Scientific Corporation
    • LivaNova PLC
    • Nihon Kohden Corporation
    • Schiller AG
    • Johnson & Johnson
    • GE Healthcare
    • Fitbit
    • BIOTRONIK
    • Biobit
    • InBody

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Cardiac Autonomic Control Market , By Product Type
    • Cardiac Autonomic Control Market , By Application
    • Cardiac Autonomic Control Market , By End User
    • Cardiac Autonomic Control Market , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Advancements in Medical Technology
  • Growing Awareness about Heart Health
  • Integration of Artificial Intelligence and Machine Learning
    • Restraints
  • Personalized Medicine
  • Remote Patient Monitoring
  • Big Data Analytics
    • Opportunities
  • Integration with Telehealth
  • Remote Patient Monitoring
  • Artificial Intelligence and Machine Learning
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Cardiac Autonomic Control Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cardiac Autonomic Control Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Heart Rate Variability (HRV) Monitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Blood Pressure Monitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 20218-2030, (US$ Bn)
  • ECG Monitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Cardiac Autonomic Control Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Cardiac Autonomic Control Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)
  • Home Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)

8. Global Cardiac Autonomic Control Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biotronik
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • MicroPort Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Nihon Kohden Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Schiller AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fitbit
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BIOTRONIK
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biobit
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • InBody
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us